Skip to main content
Clinical Trials/NCT05595720
NCT05595720
Completed
Phase 1

Effect of High Intensity Laser on Hemiplegic Shoulder Dysfunction Double Blinded, Placebo-controlled Trial

Deraya University1 site in 1 country44 target enrollmentOctober 20, 2022

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Stroke
Sponsor
Deraya University
Enrollment
44
Locations
1
Primary Endpoint
PAIN score
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

Hemiplegic shoulder pain (HSP) is a common and disabling complication following a stroke, and it may affect the quality of life. It often occurs following two to three months of stroke. Upper limb impairment is seen in 90% of patients affected by stroke.

Numerous causes have been implicated in developing HSP in stroke. This includes muscle flaccidity around the shoulder joint, shoulder subluxation, shoulder-hand syndrome, increased muscle tone, impingement syndrome, frozen shoulder, brachial plexus injury, and the thalamic syndrome.

Muscle paresis, abnormal muscle tone and loss of proprioception following stroke may render the shoulder complex unstable and therefore prone to misalignment.

In recent years, high-intensity laser therapy (HILT) has been considered as a treatment option for shoulder pain.

HILT increases microcirculation and tissue regeneration and lowers edema, inflammation, and pain with its photomechanical, thermal, electrical, and bio stimulating effects in deep tissues that cannot be reached with LILT.

It has some advantages over LILT, i.e., having higher power, greater tissue penetration capacity to deep tissues, the short emission time, and long rest periods preventing heat accumulation.

In recent studies, effectiveness of HILT has been shown in the treatment of subacromial impingement syndrome, rotator cuff tendinopathy, and frozen shoulder.

Registry
clinicaltrials.gov
Start Date
October 20, 2022
End Date
January 20, 2023
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • DISORDER MORE THAN 6 MONTHS
  • UNILATERAL
  • FIRST TIME

Exclusion Criteria

  • Iinflammatory rheumatic disease,
  • cervical radiculopathy,
  • diabetes mellitus,
  • thyroid disease,
  • coronary heart disease,
  • cardiac pacemaker,
  • neurological disease,
  • shoulder surgery, and
  • shoulder injection in the last 3 months

Outcomes

Primary Outcomes

PAIN score

Time Frame: 1 MONTH

McGill pain questioner scale, scoring from zero to 78 zero is the best score seventy eight is the worst score

FUNCTION

Time Frame: 1 MONTH

UCLA shoulder score from zero to 35 zero is the worst 35 is the best

Study Sites (1)

Loading locations...

Similar Trials